Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma (Q33863710)

29 July 2017

Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma (English)

1 reference

29 July 2017

hepatocellular carcinoma

1 reference

17

Wendy Winckler

0 references

Nabeel Bardeesy

18

object named as

Nabeel Bardeesy

0 references

Peter Caravan

19

object named as

Peter Caravan

1 reference

29 July 2017

Xintong Chen

9

0 references

Todd Golub

20

object named as

Todd R Golub

1 reference

29 July 2017

Bryan C Fuchs

1

1 reference

29 July 2017

Yujin Hoshida

2

1 reference

29 July 2017

Tsutomu Fujii

3

1 reference

29 July 2017

Lan Wei

4

1 reference

29 July 2017

Suguru Yamada

5

1 reference

29 July 2017

Gregory Y Lauwers

6

1 reference

29 July 2017

Christopher M McGinn

7

1 reference

29 July 2017

Danielle K DePeralta

8

1 reference

29 July 2017

Toshihiko Kuroda

10

1 reference

29 July 2017

Michael Lanuti

11

1 reference

29 July 2017

Anthony D Schmitt

12

1 reference

29 July 2017

Supriya Gupta

13

1 reference

29 July 2017

Andrew Crenshaw

14

1 reference

29 July 2017

Robert Onofrio

15

1 reference

29 July 2017

Bradley Taylor

16

1 reference

29 July 2017

Nabeel Bardeesy

18

1 reference

29 July 2017

Kenneth K Tanabe

21

1 reference

29 July 2017

language of work or name

English

0 references

publication date

28 February 2014

1 reference

29 July 2017

1 reference

29 July 2017

59

1 reference

29 July 2017

4

1 reference

29 July 2017

1577-1590

1 reference

Genomic responses in mouse models poorly mimic human inflammatory diseases

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Fibrosis-dependent mechanisms of hepatocarcinogenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Heparin-binding epidermal growth factor-like growth factor suppresses experimental liver fibrosis in mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

5 July 2018

Hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

5 July 2018

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Bile acid-induced epidermal growth factor receptor activation in quiescent rat hepatic stellate cells can trigger both proliferation and apoptosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

The epidermal growth factor receptor: a link between inflammation and liver cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Mechanisms of hepatic fibrogenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

TLR4 enhances TGF-beta signaling and hepatic fibrosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

The EGF receptor is required for efficient liver regeneration

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

5 July 2018

Hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Expression of epidermal growth factor and its receptor in cirrhotic liver disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Chronic hepatitis: morphology and nomenclature.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Carriage of the EGF rs4444903 A>G functional polymorphism associates with disease progression in chronic HBV infection

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086837

Expression of ErbB receptor proteins and TGF-alpha during diethylnitrosamine-induced hepatocarcinogenesis in the rat liver

29 October 2018

1 reference

12 December 2020

Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma

1 reference

12 December 2020

Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis C

1 reference

12 December 2020

Resistance to carbon tetrachloride-induced hepatotoxicity in mice which lack CYP2E1 expression

1 reference

12 December 2020

Autocrine mitogen IgEGF cooperates with c-myc or with the Hcs locus during hepatocarcinogenesis in transgenic mice

1 reference

12 December 2020

Endocytosis and intracellular trafficking of ErbBs

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FHEP.26898

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/HEP.26898

1 reference

29 July 2017

1 reference

29 July 2017

1 reference